Trial Profile
The cardiac effects of Olmesartan and Rosuvastatin in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2014
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Rosuvastatin (Primary) ; Antirheumatics
- Indications Hypercholesterolaemia; Hyperlipidaemia; Hypertension; Hypertriglyceridaemia
- Focus Pharmacodynamics
- 11 Dec 2014 New trial record